menu search

Ifx expo opened with dozens of exhibitors

iFX has reached Asia once again. The first day of the exhibition kicked off today (Wednesday) at the Centara Grand and Bangkok Convention Centre, brin...

June 21, 2023, 8:59 am

Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023

New clinical data from COVALENT-111 will be unveiled during a late-breaking poster presentation at ADA’s Scientific Sessions BMF-219, an orally deli...

June 20, 2023, 8:30 pm

Zyversa therapeutics announces a publication in journal of the american heart association linking nlrp3 inflammasomes with calcification in arteries of patients with peripheral arterial disease (pad)

PAD, characterized by vascular inflammation and associated calcification, affects 8.5 million people in the United States and contributes to more than...

June 20, 2023, 8:07 pm

Cryptocurrencies and elliott wave analysis with ryan wilday

Crypto Waves Founder Ryan Wilday discusses his Bitcoin thesis and preference for bito over GBTC. Wilday...

June 20, 2023, 11:10 am

First ever canadian bitcoin conference wraps up in toronto

The event attracted over 300 attendees and a diverse array of exhibitors, according to conference organ...

June 20, 2023, 6:14 am

American battery solutions and eve energy establish master supply agreement (msa) for prismatic lfp cells in the terastor™ bess system

MUNICH, Germany, June 16, 2023 (GLOBE NEWSWIRE) — This week at The smarter E Europe exhibition, American Battery Solutions, Inc.’s Energy Storage ...

June 16, 2023, 11:15 am

Ventyx biosciences announces initiation of dosing in a phase 1 trial of vtx3232, a novel cns-penetrant nlrp3 inhibitor

Topline data from the Phase 1 SAD/MAD trial of VTX3232 are expected in H1 2024 ENCINITAS, Calif., June 14, 2023 (GLOBE NEWSWIRE) — Ventyx Bioscience...

June 14, 2023, 11:00 am

Panbela announces sponsored research agreement to evaluate polyamine metabolic inhibitor therapy in combination with car-t cell therapy

MINNEAPOLIS, June 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutic...

June 13, 2023, 12:15 pm

Allakos presents preclinical data at eaaci hybrid congress 2023 highlighting lirentelimab and ak006 mechanisms of mast cell inhibition

– AK006 inhibits IgE mediated mast cell activation and shows similar IgE inhibitory activity as remib...

June 12, 2023, 11:02 am

Kura oncology presents late-breaking clinical data for menin inhibitor ziftomenib at 2023 european hematology association (eha) congress

– 35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg dose (RP2D) – – 33% (2/6) of patients with FLT3 c...

June 11, 2023, 7:45 am

Immunocore holdings: unlocking the immune system's hidden potential

Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispecific immunotherapies for cancer, autoimmune dis...

June 11, 2023, 3:49 am

Disc medicine: soaring on epp data release, reality may bite on limited market opportunity

Disc Medicine stock has shown outstanding growth since the company joined the Nasdaq in December last year, gaining nearly 250%. The company released ...

June 9, 2023, 3:32 pm

Disc presents positive initial data from phase 2 beacon trial of bitopertin in patients with erythropoietic protoporphyria (epp) at european hematology association (eha) 2023 congress

Consistent and dose-dependent reductions of protoporphyrin IX (PPIX), the disease-causing metabolite in EPP, were observed in patients treated with ...

June 9, 2023, 11:00 am

Biogen (biib) to end one of two parkinson's studies on biib122

Biogen BIIB announced that it is discontinuing one of the two studies on its and partner Denali Therapeutics' DNLI small molecule LRRK2 inhi...

June 6, 2023, 11:59 am

bito: comparing bitcoin with gold as a safe haven

The ProShares Bitcoin Strategy ETF closely tracks the SPDR Gold Shares ETF and offers a digital alternative to gold as a safe haven during times of un...

June 5, 2023, 6:41 am

Your guide to medications for coronary artery disease

Several medications help treat and prevent coronary artery disease (CAD). This includes statins to lower cholesterol levels, ACE inhi...

June 3, 2023, 5:59 pm

Fda expands astrazeneca (azn) lynparza label in prostate cancer

Following FDA's label-expansion approval, AstraZeneca's (AZN)/Merck's (MRK) Lynparza is the first PARP inhibit...

June 2, 2023, 1:54 pm

Bayer (bayry) & cedilla to co-develop novel cancer therapies

Bayer (BAYRY) announces licensing agreement with Cedilla Therapeutics to jointly develop and commercialize the latter's selective protein complex inhi...

June 2, 2023, 8:23 am

Kalvista pharmaceuticals to present data at the 2023 meeting of the european academy of allergy and clinical immunology (eaaci)

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

June 2, 2023, 6:30 am

Why shares of disc medicine opco climbed this week

Disc Medicine is a clinical-stage biopharmaceutical company specializing in treating blood disorders. The company's lead therapy, ...

June 1, 2023, 3:10 pm


Search within

Pages Search Results: